Enterprise Financial Services Corp Alkermes Plc. Transaction History

Enterprise Financial Services Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$13.31 - $19.41 $638 - $931	-48 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $626 - $1,019	48 New	48 $1,000
Q1 2019 Apr 26, 2019	SELL	$28.4 - $36.49 $994 - $1,277	-35 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$27.94 - $44.61 $1,173 - $1,873	-42 Reduced 54.55%	35 $1,000
Q3 2018 Oct 26, 2018	BUY	$38.6 - $46.12 $2,972 - $3,551	77 New	77 $3,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.